0
ARTICLE |

CURRENT SITUATION ON USE OF DOW CORNING SILICONE FLUID FOR SOFT TISSUE AUGMENTATION BY INJECTION

F. L. DENNETT
Arch Otolaryngol. 1966;83(5):508. doi:10.1001/archotol.1966.00760020510035.
Text Size: A A A
Published online

To the Editor: As early as 1954, independent investigators reported on the use of dimethylpolysiloxane fluids, often referred to simply as silicone fluid, for soft tissue augmentation by injection techniques. Various reports in the literature and the lay press have described the use of pure silicone fluid or mixtures of silicone fluid and some other (usually secret) materials for mammary augmentation, treatment of facial hemiatrophy, wrinkle eradication, etc.

The Dow Corning Center for Aid to Medical Research has been concerned about the problems involved by the rather indiscriminate injection of silicone fluids to people throughout the world. The articles in the lay press which have appeared since early 1965 have not diminished these problems.

Silicones, alone or in combination with other materials, intended for injection into humans are considered as "new drugs" by the Federal Food and Drug Administration.1 At the present time any work involving silicone fluid

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();